13 results
8-K
EX-99.1
BXRXQ
Baudax Bio, Inc.
10 May 23
Regulation FD Disclosure
8:01am
of the patient to laryngoscopy
Study BDX-22-006 Demographics Rocuronium BX1000 0.6 mg/kg 0.15 mg/kg 0.25 mg/kg 0.35 mg/kg Total (N=20) (N=20) (N=20) (N=20
8-K
EX-99.2
BXRXQ
Baudax Bio, Inc.
25 Apr 23
Baudax Bio Announces Positive Top-Line Final Results
9:21am
relaxation, active resistance of the patient to Poor: The presence of a single quality listed under “poor” laryngoscopy 6
Study BDX-22-006 Demographics
8-K
EX-99.2
riewzrn
20 Feb 20
Regulation FD Disclosure
5:29pm
10-K
tvv798
13 Feb 20
Annual report
5:05pm
8-K
EX-99.1
e1k0zz917a9
26 Nov 19
Entry into a Material Definitive Agreement
4:53pm
10-12B/A
EX-99.1
cy81i9qyd6rvt
8 Nov 19
Registration of securities (amended)
4:42pm
10-12B/A
EX-99.1
235zjz
5 Nov 19
Registration of securities (amended)
12:16pm
10-12B
EX-99.1
4a13egi6p11
22 Oct 19
Registration of securities
5:16pm
DRS/A
EX-99.1
0ncrxxm8o
7 Oct 19
Draft registration statement (amended)
12:00am
DRS
EX-99.1
y3tqx6tq4mf7j4guzg
24 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next